CDSCO Panel Approves Pfizer's Protocol Amendment Proposal for Marstacimab Dr. Divya Colin25 Jun 2023 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization CDSCO has approved the Protocol amendment...
Hair loss drug: Pfizer Litfulo for adults, adolescents approved by USFDA Ruchika Sharma24 Jun 2023 11:30 AM ISTLITFULO is a kinase inhibitor which inhibits Janus kinase 3 (JAK3) and the tyrosine kinase expressed in hepatocellular carcinoma (TEC) family of...
Pfizer gets USFDA approval for Talzenna, Xtandi combo for prostate cancer treatment Ruchika Sharma21 Jun 2023 12:30 PM ISTTALZENNA (talazoparib) is an oral inhibitor of poly ADP-ribose polymerase (PARP), which plays a role in DNA damage repair.
Pfizer expects to run out of syphilis drug supply for children soon Ruchika Sharma14 Jun 2023 3:34 PM ISTPfizer has warned that a drug used to treat syphilis and other bacterial infections in children could run out by the end of June because it has had to...
Side effects of COVID vaccine: BioNTech faces first German lawsuit Ruchika Sharma12 Jun 2023 10:00 AM ISTThe plaintiff claims she suffered upper-body pain, swollen extremities, fatigue and sleeping disorder due to the vaccine.
Kerala CM holds talks with Pfizer over opening of research centre in Kerala Ruchika Sharma10 Jun 2023 5:04 PM ISTThe Pfizer officials also shared their interest in working with the state's new Digital Science Park, inaugurated recently by Prime Minister Narendra...
Patent infringement: Moderna, Pfizer sued by Promosome over mRNA technology in COVID vaccines Ruchika Sharma8 Jun 2023 1:30 PM ISTPromosome accused the companies of copying technology that allows for doses of mRNA that are small enough to use safely and effectively in the...
Novavax exec says its new COVID shot should work against variants on rise Ruchika Sharma6 Jun 2023 2:30 PM ISTGaithersburg: Novavax Inc's head of research and development has said an updated COVID-19 vaccine the company is already producing is likely to...
Antibiotics combo promising against multidrug-resistant bacterial infections: Result from two phase 3 trials Medha Baranwal6 Jun 2023 10:45 AM ISTUSA: Findings from two phase 3 trials have shown the investigational antibiotic combination aztreonam-avibactam (ATM-AVI) to be safe and effective for...
Pfizer announces positive results from phase 3 studies of novel antibiotic combination aztreonam-avibactam in treating serious bacterial infections Ruchika Sharma4 Jun 2023 2:00 PM ISTNew York: Pfizer Inc. has announced positive results from the Phase 3 program comprising the REVISIT and ASSEMBLE studies evaluating the efficacy,...
Pfizer bags USFDA nod for RSV vaccine Abrysvo for older adults Ruchika Sharma1 Jun 2023 12:00 PM ISTThe FDA's decision is based on the data from the pivotal Phase 3 clinical trial (NCT05035212) RENOIR (RSV vaccine Efficacy study iNOlder adults...
Pfizer India, Apollo Hospital launch Centre of Excellence for adult vaccination in Hyderabad MD Bureau28 May 2023 2:00 PM ISTThe centre will immunize against various vaccine-preventable diseases such as Pneumococcal disease, Hepatitis A and B, Human Papilloma Virus (HPV),...
